Dolby Laboratories (NYSE:DLB) Stock Has Consensus Target Price of $76.67

Dolby Laboratories logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Hold” rating on Dolby Laboratories, with three holds and two buys among five covering firms; the average 12-month price target is $76.67.
  • Fiscal Q4 revenue rose 21.7% year over year to $373.5 million, and EPS of $1.25 topped estimates. However, FY2027 revenue guidance fell short of consensus, raising concerns despite the quarterly beat.
  • Dolby raised its quarterly dividend from $0.36 to $0.39 per share and has authorized up to $350 million in share repurchases.
  • MarketBeat previews top five stocks to own in December.

Shares of Dolby Laboratories (NYSE:DLB - Get Free Report) have received an average recommendation of "Hold" from the five ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $76.67.

A number of equities analysts recently weighed in on DLB shares. Robert W. Baird reduced their price target on Dolby Laboratories from $62.00 to $60.00 and set a "neutral" rating for the company in a report on Thursday. Rosenblatt Securities dropped their target price on Dolby Laboratories from $85.00 to $80.00 and set a "buy" rating for the company in a report on Monday. Weiss Ratings raised shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, September 9th. Wall Street Zen lowered shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Finally, Zacks Research raised shares of Dolby Laboratories from a "strong sell" rating to a "hold" rating in a research report on Friday, November 13th.

Check Out Our Latest Analysis on Dolby Laboratories

Latest Dolby Laboratories News

These are some of the DLB news items that stood out recently:

  • Positive Sentiment: Fiscal Q4 revenue rose 21.7% year over year to $373.5 million, slightly ahead of estimates, while EPS of $1.25 also topped expectations. Q4 earnings and revenue results
  • Positive Sentiment: Long-term licensing strengths include advanced audio and imaging patents, which generated more than half of licensing revenue; Dolby’s Video Distribution Patent Program grew to 47 licensors. Long-term investor takeaways
  • Negative Sentiment: Forward guidance is the key concern: Dolby’s Q1 FY2027 revenue outlook of $285–$305 million is well below the roughly $358 million consensus, and its FY2027 revenue forecast of $1.4 billion trails expectations near $1.5 billion. The outlook prompted selling despite the quarterly beat. Shares fall on FY2027 guidance

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CAO Ryan Nicholson sold 1,183 shares of the business's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares in the company, valued at $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP John D. Couling sold 7,667 shares of the company's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the transaction, the senior vice president owned 166,803 shares of the company's stock, valued at approximately $9,804,680.34. This represents a 4.39% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 16,517 shares of company stock valued at $995,963. Company insiders own 37.93% of the company's stock.

Institutional Trading of Dolby Laboratories

A number of hedge funds have recently made changes to their positions in DLB. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its stake in Dolby Laboratories by 4.9% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 4,300 shares of the electronics maker's stock worth $253,000 after purchasing an additional 200 shares during the last quarter. Frank Rimerman Advisors LLC increased its stake in Dolby Laboratories by 2.7% during the third quarter. Frank Rimerman Advisors LLC now owns 8,403 shares of the electronics maker's stock valued at $494,000 after purchasing an additional 223 shares during the last quarter. CX Institutional raised its holdings in shares of Dolby Laboratories by 2.7% during the third quarter. CX Institutional now owns 13,074 shares of the electronics maker's stock worth $768,000 after purchasing an additional 347 shares during the period. Sanctuary Advisors LLC lifted its position in shares of Dolby Laboratories by 8.9% in the 1st quarter. Sanctuary Advisors LLC now owns 8,022 shares of the electronics maker's stock worth $482,000 after buying an additional 657 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in shares of Dolby Laboratories by 11.9% in the 3rd quarter. Signaturefd LLC now owns 6,835 shares of the electronics maker's stock valued at $402,000 after buying an additional 729 shares during the period. Institutional investors and hedge funds own 58.56% of the company's stock.

Dolby Laboratories Price Performance

DLB traded down $1.24 during trading on Thursday, reaching $55.53. 438,311 shares of the company's stock were exchanged, compared to its average volume of 848,875. The company's fifty day simple moving average is $60.80 and its 200-day simple moving average is $59.37. The stock has a market capitalization of $5.20 billion, a P/E ratio of 20.58 and a beta of 0.79. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $69.95.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.05. Dolby Laboratories had a return on equity of 11.78% and a net margin of 18.14%. The business had revenue of $373.54 million during the quarter, compared to analysts' expectations of $372.76 million. During the same quarter in the previous year, the firm posted $0.99 EPS. The company's revenue for the quarter was up 21.7% on a year-over-year basis. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. Equities analysts forecast that Dolby Laboratories will post 3.36 EPS for the current year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 9th. Investors of record on Tuesday, December 1st will be paid a dividend of $0.39 per share. The ex-dividend date is Tuesday, December 1st. This is a positive change from Dolby Laboratories's previous quarterly dividend of $0.36. This represents a $1.56 annualized dividend and a yield of 2.8%. Dolby Laboratories's dividend payout ratio (DPR) is presently 61.28%.

Dolby Laboratories declared that its Board of Directors has initiated a share buyback plan on Thursday, July 30th that allows the company to repurchase $350 million in shares. This repurchase authorization allows the electronics maker to repurchase up to 7% of its shares through open market purchases. Share repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

See Also

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines